1. Home
  2. KDP vs IQV Comparison

KDP vs IQV Comparison

Compare KDP & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Keurig Dr Pepper Inc.

KDP

Keurig Dr Pepper Inc.

HOLD

Current Price

$30.79

Market Cap

41.8B

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$240.03

Market Cap

35.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KDP
IQV
Founded
1981
1982
Country
United States
United States
Employees
N/A
93000
Industry
Beverages (Production/Distribution)
Biotechnology: Commercial Physical & Biological Resarch
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.8B
35.1B
IPO Year
2007
2013

Fundamental Metrics

Financial Performance
Metric
KDP
IQV
Price
$30.79
$240.03
Analyst Decision
Buy
Strong Buy
Analyst Count
15
16
Target Price
$32.27
$227.13
AVG Volume (30 Days)
12.4M
1.4M
Earning Date
04-23-2026
05-05-2026
Dividend Yield
3.18%
N/A
EPS Growth
45.71
4.67
EPS
0.24
1.61
Revenue
$16,603,000,000.00
$9,739,000,000.00
Revenue This Year
$58.73
$6.77
Revenue Next Year
$14.29
$5.89
P/E Ratio
$126.17
$149.84
Revenue Growth
8.16
41.60
52 Week Low
$24.88
$154.50
52 Week High
$35.94
$251.36

Technical Indicators

Market Signals
Indicator
KDP
IQV
Relative Strength Index (RSI) 52.00 64.22
Support Level $29.78 $222.95
Resistance Level $31.91 $247.52
Average True Range (ATR) 0.98 7.13
MACD 0.07 -0.72
Stochastic Oscillator 50.17 81.64

Price Performance

Historical Comparison
KDP
IQV

About KDP Keurig Dr Pepper Inc.

Keurig Dr Pepper was established in 2018 following a merger between Keurig Green Mountain Coffee and Dr Pepper Snapple. The company manufactures and distributes coffee systems (including coffee brewers and single-serve coffee pods) under the Keurig and Green Mountain brands, as well as ready-to-drink beverages including flavored (non-cola) sparkling soft drinks under well-known brands such as Dr Pepper, Snapple, and Canada Dry. On Aug. 25, 2025, the firm announced a definitive agreement to acquire coffeemaker JDE Peet's for $18 billion in cash, with the deal now scheduled to close in April 2026. Following the merger, it plans to split into two US-listed entities to focus on refreshment beverages in North America and global coffee separately.

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Share on Social Networks: